The latest closing stock price for EYEPOINT PHARMACEUTICALS, INC as of November 07, 2024 is 11.59.
An investor who bought $1,000 worth of EYEPOINT PHARMACEUTICALS, INC stock at the IPO in 2018 would have $8 today, roughly 0 times their original investment - a 0.11% compound annual growth rate over 7 years.
The all-time high EYEPOINT PHARMACEUTICALS, INC stock closing price was 37.70 on October 03, 2018.
The EYEPOINT PHARMACEUTICALS, INC 52-week high stock price is 30.99, which is 167.4% above the current share price.
The EYEPOINT PHARMACEUTICALS, INC 52-week low stock price is 5.86, which is 49.4% below the current share price.
The average EYEPOINT PHARMACEUTICALS, INC stock price for the last 52 weeks is 14.93.
An investor who bought $1,000 worth of EYEPOINT PHARMACEUTICALS, INC stock at the IPO in 2018 would have $8 today, roughly 0 times their original investment - a 0.11% compound annual growth rate over 7 years.
The all-time high EYEPOINT PHARMACEUTICALS, INC stock closing price was 37.70 on October 03, 2018.
The EYEPOINT PHARMACEUTICALS, INC 52-week high stock price is 30.99, which is 167.4% above the current share price.
The EYEPOINT PHARMACEUTICALS, INC 52-week low stock price is 5.86, which is 49.4% below the current share price.
The average EYEPOINT PHARMACEUTICALS, INC stock price for the last 52 weeks is 14.93.